muscimol has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergman, H; DeLong, MR; Wichmann, T | 1 |
DeLong, MR; Kliem, MA; Wichmann, T | 1 |
Baron, MS; DeLong, MR; Ma, D; Wichmann, T | 1 |
Kojima, J; Matsumura, M | 1 |
4 other study(ies) available for muscimol and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Afferent Pathways; Animals; Bicuculline; Brain Mapping; Chlorocebus aethiops; Dominance, Cerebral; Dose-Response Relationship, Drug; Globus Pallidus; Ibotenic Acid; Motor Activity; Motor Neurons; Motor Skills; Muscimol; Muscle Rigidity; Muscles; Nerve Net; Neurons; Parkinson Disease, Secondary; Synaptic Transmission; Thalamic Nuclei | 1994 |
Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Carrier Proteins; Dopamine Plasma Membrane Transport Proteins; Excitatory Amino Acid Agonists; GABA Agonists; Ibotenic Acid; Macaca mulatta; Membrane Glycoproteins; Membrane Transport Proteins; Microinjections; Motor Activity; Muscimol; Nerve Tissue Proteins; Neurons; Parkinson Disease, Secondary; Substantia Nigra | 2001 |
Effects of transient focal inactivation of the basal ganglia in parkinsonian primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Behavior, Animal; Disease Models, Animal; GABA Agonists; Globus Pallidus; Hypokinesia; Macaca mulatta; Microinjections; Motor Activity; Muscimol; Parkinson Disease, Secondary; Subthalamic Nucleus; Treatment Outcome | 2002 |
The role of the pedunculopontine tegmental nucleus in experimental parkinsonism in primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Afferent Pathways; Animals; Basal Ganglia; Brain Stem; Cerebral Cortex; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Efferent Pathways; Kainic Acid; Macaca; Male; Models, Neurological; MPTP Poisoning; Muscimol; Neurons; Parkinsonian Disorders; Pons; Psychomotor Performance; Stereotaxic Techniques; Substantia Nigra; Tegmentum Mesencephali | 2001 |